Corcept Therapeutics CORT Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's total costs & expenses?
- Corcept Therapeutics (CORT) reported total costs & expenses of $214.5M in Q1 2026.
- How has Corcept Therapeutics's total costs & expenses changed year-over-year?
- Corcept Therapeutics's total costs & expenses increased by 39.5% year-over-year, from $153.8M to $214.5M.
- What is the long-term trend for Corcept Therapeutics's total costs & expenses?
- Over 4 years (2021 to 2025), Corcept Therapeutics's total costs & expenses has grown at a 31.2% compound annual growth rate (CAGR), from $241.5M to $716.61M.
- What does total costs & expenses mean?
- The sum of all money a company spends to operate its business.
- How do you interpret total costs & expenses?
- Rising costs relative to revenue indicate margin compression, while stable or falling costs relative to revenue suggest operating leverage.
- How does total costs & expenses compare across companies?
- Used to assess overall cost discipline across the entire organization compared to industry benchmarks.